CalciMedica Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	22.22	5.84	17.04	8.87	6.92	5.6
Research & Development	15.86	8.35	18.9	20.96	30.58	22.97
Operating Expenses	38.08	14.19	35.95	29.83	37.5	28.57
Operating Income	-38.08	-14.19	-35.95	-29.83	-37.5	-28.57
Other Expense / Income	-3.72	-6.37	-0.13	-2.3	-0.47	-0.19
Pretax Income	-34.36	-7.82	-35.82	-27.53	-37.04	-28.38
Net Income	-34.36	-7.82	-35.82	-27.53	-37.04	-28.38
Preferred Dividends	0	1.32	0	7.19	7.06	4.32
Net Income Common	-34.36	-9.14	-35.82	-34.72	-44.09	-32.7
Shares Outstanding (Basic)	4	0	2	0	0	1
Shares Outstanding (Diluted)	4	0	2	0	0	1
Shares Change	5354.75%	-94.57%	220.31%	401.43%	-88.45%	-
EPS (Basic)	-7.66	-111.16	-23.66	-73.50	-467.74	-40.04
EPS (Diluted)	-7.66	-111.16	-23.66	-73.50	-467.74	-40.04
Free Cash Flow	-25.81	-11.76	-31.99	-33.09	-31.82	-29.68
Free Cash Flow Per Share	-5.75	-143.00	-21.13	-69.99	-337.51	-36.36
EBITDA	-34.3	-7.77	-35.3	-27.14	-36.73	-28.2
Depreciation & Amortization	0.06	0.05	0.52	0.4	0.3	0.18
EBIT	-34.36	-7.82	-35.82	-27.53	-37.04	-28.38

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).